http://rdf.ncbi.nlm.nih.gov/pubchem/patent/HU-0000964-A2
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D217-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D217-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D217-06 |
| filingDate | 1998-03-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1342eab02e1bde6dad782215a9801384 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_83381ef346466012b735950b59705d45 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6fafdead5b546b58dd08be9b27b75cea |
| publicationDate | 2000-09-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | HU-0000964-A2 |
| titleOfInvention | Isocinolylbenzamide derivatives with anticonvulsant activity, method for their preparation and pharmaceutical compositions containing these compounds |
| abstract | SUMMARY OF THE INVENTION The present invention is directed to compounds of the general formula (I) having an anti-selective action, wherein R 1 is hydrogen alkyl, alkylpyrrolidated, optionally substituted with a hydrofoam or alkypyrite, alkenyl, alkynyl, alkylcarbonyl, mainmyl, trifluoroacetyl or alkylphenyl; R2 is a hydrogen atom, or at most three, selected from the group consisting of: and / or tuberculosis: dead gene, nitrate, cyan, azal, trifluoro-methyl, trifluoromethyl, trifluoroacetyl, trifluoroacetyl; methyl) diazirinyl, alkyl, alkenyl, alkynyl, perchloralkyl, cycloalkyl, cycloalkylalkyl, alkyloxy, alkylcarbonyl, cycloalkylxyl, cycloalkylcarbonyl, cycloalkylalkyloxy , (cycloalkylalkyl) carbonyl, phenyl, phenoxy, benzylxyl, benzyl, phenylalkyl, alkylthio, alkylphenyl, (dialkylamine) filtrate; amine) -phenyl, (dialkylamino) carbonyl, (alkylamino) carbonyl, carbamoyl powder, or -NR5R6 -based tubular cores, of which R5 is hydrogen or alkyl, and R6 is hydrogen, alkyl, methyl, alkyloxy, alkyloxy, alkyloxy, alkyloxy, alkyloxy, alkyloxy, alkyloxy, alkyloxy, alkyloxy, alkyloxy, alkyloxy, alkynyl, alkyloxy, alkyloxy, alkyloxy, alkyloxy, alkyloxy, alkyloxy, alkyloxy, alkynyl, alkyloxy, alkyloxy, alkynyl, alkyloxy, alkyloxy, alkynyl, alkyloxy, alkynyl, alkyloxy, alkyloxy, alkychlorine carbyanyl or alkylcarbonyl; or two R2 together form a saturated or unsaturated, in the case of an added hydrofoil or anthracite tube, a carburetor tube; and each of R 3 and R 4 is independently hydrogen or alkyl, or the two R 3 -binding and / or the two R 4 -stands together form a single-spiral tube, with the proviso that at least one of R 3 and R 4 represents a hydrogen atom or is bound to its therapeutically parent salts, with the proviso that it is thermoplastic. the compound may not be 1-methyl-6- (benzylamino) -1,2,3,4-tetrahydroquinoline or 1,2,2-dimethyl-6- (benzylamino) -1,2,3,4-tetrahydrofurine. The invention also encompasses methods for preparing the compounds and their use as therapeutic agents, and more particularly pharmaceutical compositions containing the compound. ŕ |
| priorityDate | 1997-12-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 228.